Table 1 Characteristics of the cohort (n = 1051)
From: Retention in Georgia opioid substitution therapy program and associated factors
% of patients | n/N of patients | Median; IQR [25–75%] | |
|---|---|---|---|
Age | 40 [34–46] | ||
Age group 1 (≤40) | 49% | 515/1051 | |
Age group 2 (>40) | 51% | 536/1051 | |
Gender | |||
Male | 97.2% | 1022/1051 | |
Female | 2.8% | 29/1051 | |
Socially vulnerable | 21.5% | 226/1051 | |
Hepatitis C status (confirmed cases) | 48.8% | 513/1051 | |
HIV status | 4.19% | 44/1051 | |
Came from other OST program/transfers | 27.7% | 291/1051 | |
Retention in GF program (months) | 8.0; IQR [2.9–31.5] | ||
Retention in OST (months) | 13.3; IQR [4.2–37.7] | ||
>3-month retention | 80.3% | 844/1051 | |
>6-month retention | 67.5% | 710/1051 | |
>9-month retention | 60.1% | 632/1051 | |
>12-month retention | 52.9% | 556/1051 |